SUMMARY In 35 patients aged 18 to 69 years (mean 48) with clinical, electrocardiographic, or electrophysiological evidence of normal sinus node function, the effect of intravenous propranolol (0 1 mg/kg) was assessed on 3 indices of sinus node function. The drug significantly prolonged sinus node cycle length (12%), slightly prolonged the corrected sinus node recovery time (15%), and slightly but insignificantly lengthened sinuatrial conduction time. Propranolol may be administered safely in patients with normal sinus node function without the fear of producing severe sinus bradycardia, sinuatrial block, sinuatrial pauses, or prolonged sinus asystole, after spontaneous or stimulation-induced conversion of a tachycardia.
For over a decade, propranolol has been used extensively in the management of patients with arrhythmias (Rowlands et al., 1965; Bath, 1966) . Several studies have reported the electrophysiological effects of propranolol in isolated tissue preparations (Davis and Temte, 1968; Pollen et al., 1969) , in the intact animal (Priola, 1973) , and in man (Seides et al., 1974) . Despite a large number of publications, there is little information on the electrophysiological effects of propranolol on the sinus node function in man (Grendahl et al., 1975; Strauss et al., 1976b) . Previous studies (Seides et al., 1974) in general analysed the effect of propranolol on only one index of sinus node function, that is the changes in sinus node cycle length or rate. Except for a preliminary report (Chuquimia et al., 1977) from this laboratory, few data are available on the effects of propranolol in patients with normal sinus node function, in particular on the response of the sinus node to overdrive suppression and on sinuatrial conduction time. Recently Strauss et al. (1976b) 18 August 1978 fibrillation, atrial flutter, or supraventricular tachycardia, which inherently produce overdrive suppression of the sinus node, the necessity to learn the effects of propranolol on various indices of normal sinus node function was realised. The purpose of this study was to analyse the effect of intravenous propranolol on sinus node function in patients with clinical and electrophysiological evidence of normal sinus node function.
Subjects and methods
Electrophysiological studies were performed in 35 patients. Patients ranged in age from 18 to 69 years (mean 48), with 16 men and 19 women. A complete history and physical examination were recorded. In each patient routine laboratory data, a standard 12 lead electrocardiogram, and a chest x-ray film were obtained. The patients included in this study consistently showed resting normal heart rates (> 60/min) on serial electrocardiograms and showed no electrocardiographic ( during sinus rhythm after every 8th sinus cycle for evaluation of sinuatrial conduction time. The entire sinus cycle was scanned by the placement of premature atrial beats of increasing prematurity in steps of 10 to 20 ms until the atrial refractory period was reached. After the sequence of premature atrial beats, spontaneous sinus rhythm was observed for another period of 2 minutes before analysis of sinus node recovery time. The sinus node recovery time was measured as previously described (Narula et al., 1972) by atrial pacing at 2 different cycle lengths (500 and 430 ms) for a period of 2 minutes at each level. Atrial pacing at cycle lengths shorter than 430 ms was not used, as previous studies Mandel et al., 1971) have reported a decrease in sinus node recovery time with shorter pacing cycle lengths. Immediately after atrial pacing was stopped, 10 spontaneous sinus cycles were recorded and analysed. A rest period of 2 minutes was provided between each atrial pacing rate to permit sinus rhythm to return to control levels. In our study, the sinus cycles usually returned to control levels in less than 1 minute.
After control determinations were completed, propranolol was administered intravenously in a dosage of 0-1 mg/kg bodyweight at a rate of 1 mg/min. Total dose ranged from 5 to 10 mg. This dosage regimen has been reported (Seides et al., 1974) to produce average plasma levels of 13-6 ng/ml for 45 to 60 min after administration of propranolol. Ten minutes after the infusion of the last drop of propranolol, 30 sinus cycles were recorded to obtain the post-propranolol mean sinus cycle length. Thereafter, studies were repeated as in control to measure sinuatrial conduction time and sinus node recovery time. These studies were usually completed in ' 30 minutes after the last dose of propranolol was given.
The blood pressure was carefully monitored throughout: the drop in systolic pressure was . 10 mmHg in all cases. No complications requiring treatment occurred in any patient either during or after the study. The atrial stimulation studies (regular atrial pacing or premature atrial beats) did not produce any bouts of atrial fibrillation or flutter throughout the study. In none of the cases with a history of supraventricular tachycardia was the measurement of sinus node recovery time or sinuatrial conduction time affected by atrial stimulation studies. Regular atrial pacing at cycle lengths used for sinus node recovery time did not initiate supraventricular tachycardia. During scanning of the sinus cycle by premature atrial beats, supraventricular tachycardia was initiated (3 out of 7) with very early premature atrial beats and not during the zone of sinus node reset used for estimating sinuatrial conduction time. In order to enhance relaxation, patients were studied in a quiet atmosphere and a relatively dark room using as little light as was necessary for the operation of the stimulator and the physiological recorder.
In each patient the intervals between successive atrial depolarisations were measured from the bipolar high right atrial electrogram. During the sequence of premature atrial beats, the following intervals were measured: (1) AjAj which is defined as the interval between the 2 consecutive sinus cycles; (2) A1A2 the interval between the atrial electrograms of sinus origin and the premature atrial beat; (3) A2A3 (return cycle) the interval between the premature atrial beat and the succeeding sinus beat. The estimated sinuatrial conduction time was calculated by the recently described method of Strauss et al. (1976a) 711 102) and after propranolol it ranged from 705 to 1090 ms (mean and SD 860 + 107). After propranolol the sinus node cycle length increased by a range of 6 to 295 ms (mean 94) or by a mean of 12 per cent; this increase was statistically significant (P < 0.005) (Fig.) None of the patients manifested any electrocardiographic evidence of 20 sinuatrial block or sinuatrial pauses after propranolol administration.
(2) SINUATRIAL CONDUCTION TIME In 2 patients (cases 26 and 32), the sinuatrial conduction time during control was 175 and 118 ms, and it could not be calculated after propranolol as the zone of sinus node reset could not be defined (Table) . In the remaining 33 patients, the control sinuatrial conduction time ranged from 70 to 246 ms (mean 166 ± 49) and after propranolol it ranged from 100 to 285 ms (mean 182 + 49). With propranolol, the sinuatrial conduction time was shortened (range 7 to 92 ms) in 12 and lengthened (range 2 to 110 ms) in 21 patients. The changes in sinuatrial conduction time after propranolol were not statistically significant.
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patients, in whom it was noted to be the second or the third sinus node cycle (Table) .
The control corrected sinus node recovery time after atrial pacing at cycle length of 500 ms ranged from 83 to 520 ms (mean 247 ± 113) and after e cycle length propranolol ranged from 90 to 605 ms (mean 284 + and SD 766 + 115) (Fig.) With propranolol, the increase (15%) in mean study of patients with normal sinus node function, corrected sinus node recovery time (from 247 to 284) there was no difference in response to propranolol after atrial pacing at a cycle length of 500 ms was related to the presence or absence of associated statistically significant (P < 0.025). However, the arrhythmias. increase in corrected sinus node recovery time (from 235 to 272 ms) after atrial pacing at a cycle Discussion length of 430 ms was not statistically significant. In addition, when the data of maximum or the longest In the past 6 years, atrial pacing studies have been corrected sinus node recovery time at either of the extensively used for electrophysiological evaluation atrial pacing cycle lengths are reviewed, the maxi-of sinus node function in man, both for investigative mum time: (a) increased from a mean of 284 + 130 and clinical purposes.With the increasing use ofsuch to 317 ± 112 ms and (b) lengthened in 25 and techniques, it has become apparent that at times in shortened in 10 patients after propranolol. In this patients with previously documented sinus node dysfunction, the evaluation of sinus node function by electrophysiological means is within normal limits at the time of the study. These observations raise questions as to whether the electrophysiological testing procedures are inadequate and unreliable or whether the laboratory results return to normal because of an increase in release of stored catecholamines resulting from the stress of cardiac catheterisation. If the latter possibility is true, then it may be argued that patients requiring evaluation of sinus node function for clinical purposes may be analysed with greater accuracy by blocking the effect of increased catecholamines with propranolol administration.
Recently Strauss et al. (1976b) attempted to evaluate this consideration in 10 patients who were thought to have symptomatic sinus node dysfunction. However, only 2 of the 10 patients had abnormal corrected sinus node recovery time during control and both showed a severe prolongation of corrected sinus node recovery time after propranolol. In 5 other patients, the corrected sinus node recovery time changed by ' 58 ms with propranolol. Since the effect of propranolol on normal sinus node function was not known, their observations cannot be reviewed from a proper perspective and have failed to satisfy the questions raised above. Their study left several questions unanswered. Does propranolol have a significant effect on sinus node recovery time in both patients with normal and abnormal sinus nodes? Is the severe prolongation of sinus node recovery time noted in 2 of the 10 cases an unusual response, or is it indicative of severe sinus node dysfunction ?
Our data in patients with normal sinus node function show that with propranolol sinus cycles lengthened significantly (P < 0.005) with an average increase of 12 per cent. This prolongation in sinus cycle length is slightly less as compared with 16 per cent (Seides et al., 1974) and 22 per cent (Stern and Eisenberg, 1969) reported by others. The difference between our results and those of others may be explained by the fact that our patients were premedicated with pentobarbitone sodium whereas others obtained their data in nonsedated patients, possibly with higher levels of released catecholamines. The greater the betaadrenergic stimulus, the greater the response to beta-adrenergic blockade. In our patients, the control sinus cycle lengths noted at the time of the study were usually similar to those noted on routine electrocardiograms. This suggests that possibly there was no obvious increase in catecholamine release during the electrophysiological study.
After propranolol, though the mean corrected 713 sinus node recovery time lengthened after each of the atrial pacing levels (120/min and 140/min), it was statistically significant only after atrial pacing at 120/min. In addition, in 49 per cent ofthe patients the corrected sinus node recovery time, at either of the pacing cycle lengths, decreased after propranolol. Previous studies (Breithardt and Seipel, 1976) have indicated a faster conduction into the sinus node with sympathetic stimulation or with parasympathetic blockade after atropine. Therefore, the converse is also possible, that is an increased conduction delay or entrance block into the sinus node with sympathetic blockade. A decrease in corrected sinus node recovery time with propranolol may be explained on the basis of an enhanced entrance block into the sinus node and which, compared with the control levels, was manifested in some at lower atrial pacing rates. However, a lack of significant increase in sinuatrial conduction time with propranolol fails to support such a possibility. If, in fact, propranolol enhances entrance block into the sinus node, it may possibly obscure the demonstration of sinus node dysfunction and may mask prolongation of the sinuatrial conduction time. Recently reported observations (Strauss et al., 1976b ) of a distinct prolongation of corrected sinus node recovery time with propranolol in some and not all of the cases with clinically diagnosed sinus node dysfunction may suggest that: (a) if in patients with sinus node dysfunction, as discussed above, a protection from overdrive suppression does exist, it does not apply to all ofthe cases with sick sinus node; and (b) depending upon the response to propranolol, it may be possible to differentiate the various underlying mechanisms responsible for sick sinus syndrome, that is abnormalities of sinuatrial conduction and of the generator function of the sinus node.
During experiments in isolated tissues, it has been previously noted (Rosenbleuth, 1950) that in order to produce slower sinus rates or asystole it is necessary to affect all sinus node pacemaker fibres by acetylcholine, whereas only a few sinus node pacemaker fibres need be accelerated by norepinephrine to produce an increment in the heart rate. Therefore, it may be reasoned that in patients with sick sinus node, only a few sinus node pacemaker fibres may be functioning under the influence of available catecholamines which are sufficient to sustain sinus rhythm. In such patients, a withdrawal of catecholamine influences and beta-adrenergic blockade with propranolol may not only result in slower sinus node rates but also show a pronounced suppression to overdrive pacing or a distinct prolongation of the sinus node recovery time.
In our series, the maximum corrected sinus node recovery time at either of the atrial pacing rates showed a mean prolongation of 33 ms (11%) with propranolol. None of the patients showed a severe prolongation in corrected sinus node recovery time similar to that observed by Strauss et al. (1976b) in 2 of their 10 cases with sinus node dysfunction. On the basis of present data, it may be suggested that in the dosage used in this study and in therapeutic doses, propranolol may be safely administered when required to patients with electrophysiologically normal sinus node function without affecting it adversely. Accordingly, the evaluation of sinus node recovery time with and without propranolol may be clinically useful, before the institution of propranolol therapy, for detecting patients in whom a distinct adverse effect on sinus node function may occur, though extrapolation to patients on longterm oral treatment with propranolol may not be valid.
In all but 4 of the cases in our series, the first escape sinus node cycle after cessation of atrial pacing was the longest, both during control and after propranolol. This suggests that the secondary pauses are not common in cases with normal sinus node function and, when noted, may be suspicious of an overt or latent sinus node dysfunction. It may also be indirectly concluded that after propranolol administration a conversion of supraventricular tachycardia when associated with a long period of asystole probably indicates a sick sinus node. The asystole should not be interpreted merely as an expected side effect of propranolol. Such patients should be further investigated, in the absence of propranolol to confirm the diagnosis of sick sinus syndrome.
Previous workers (Breithardt and Seipel, 1976 ) have shown that sinuatrial conduction time is affected by autonomic influences, that is shortened by parasympathetic blockade or sympathetic stimulation. Our data show that though after propranolol there was a slight increase in the mean sinuatrial conduction time for the entire group, it was not statistically significant. It is difficult to evaluate properly the effect of propranolol on sinuatrial conduction time because of the limitations inherent in the present technique for its estimation (Strauss and Wallace, 1976) .
The dosage of propranolol used in this study is similar to that used by others during electrophysiological studies in man (Seides et al., 1974; Strauss et al., 1976b) . Propranolol in these doses produces 20 to 30 per cent blockade of exerciseinduced sinus tachycardia and requires a tenfold increase in the dose of isoprenaline to produce a given level of sinus tachycardia (Coltart and Shand, 1970) . The plasma level resulting from this dosage regimen has been shown to have a significant betaadrenergic blocking effect. Mean serum levels of 13'6 ng/ml have been reported 45 to 60 minutes after propranolol administration with this dosage regimen (Seides et al., 1974) . Our studies were generally completed within 30 min of the last dose of propranolol. In addition, this dosage regimen was selected to avoid unnecessary side effects or complications, that is hypotension which in turn may artificially alter the sympathetic and parasympathetic influences and thereby confuse the interpretation of the results. The results of the present study of an increase in sinus node cycle length, lengthening of corrected sinus node recovery time, and a possible prolongation of sinuatrial conduction time may all be explained on the basis of the betaadrenergic blocking effect of propranolol on the sinus node and the atrial myocardium. 
